Clinical Trials Directory

Trials / Completed

CompletedNCT04577430

Effects of Dexmedetomidine on Cardiac Electrophysiology in Patients Under General Anesthesia During Perioperative Period

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Yangzhou University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Perioperative stress may increase the incidence of adverse events in the cardiovascular system and lead to poor prognosis. Dexmedetomidine is a highly selective α2 adrenergic receptor agonist, which can inhibit stress response and reduce hemodynamic fluctuations. In different usage plans, dexmedetomidine can have different effects on hemodynamics, myocardial electrical activity, cardiac function. The main purpose was to observe its effects on myocardial electrophysiology and cardiac function during perioperative period. The secondary purpose was to explore the optimal dose of dexmedetomidine that has the least adverse effects on perioperative electrocardia action and cardiac function

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineThe loading dose with 0.5 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts
DRUGDexmedetomidineThe loading dose with 1 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts
DRUGDexmedetomidineThe loading dose with 1 μg/kg, maintenance dose with 1 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology of the patients' hearts
DRUGNormal salineNormal saline is used to observe the effect on the electrophysiology of the patients' hearts

Timeline

Start date
2019-09-08
Primary completion
2021-02-01
Completion
2021-03-16
First posted
2020-10-06
Last updated
2021-08-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04577430. Inclusion in this directory is not an endorsement.